Ewing Sarcoma

What Is Ewing Sarcoma?

Ewing sarcoma is a rare cancer that typically develops in the bones or the soft tissues surrounding them. Though it can occur at any age, it is most often diagnosed in children and teenagers. This type of cancer belongs to a family of tumors that share similar features and respond to many of the same treatments, making early detection and specialized care essential.

Ewing tumors are most commonly found in the bones—especially in the pelvis, chest wall (such as the ribs or shoulder blades), and the long bones of the extremities. However, they can also arise in soft tissues elsewhere in the body, referred to as extraosseous Ewing sarcoma. Regardless of location, the most frequent symptom is persistent pain near the tumor. Other signs may include swelling or a lump, which can sometimes feel warm to the touch, as well as fever or an overall sense of being unwell. Any ongoing pain, swelling, or unusual lumps should be assessed by a doctor as soon as possible.

Although Ewing sarcoma accounts for only about 1% of childhood cancers, approximately 200 new cases are diagnosed in the United States each year. The disease is most prevalent in teenagers but can also affect younger children and adults in their 20s and 30s. It tends to occur more frequently in males and is rarely seen in African American or other non-White populations.

There are currently no standardized screening methods for Ewing sarcoma, which makes early symptom recognition especially important. At the CU Cancer Center, our team of experts is dedicated to delivering personalized, cutting-edge care to patients with Ewing sarcoma. From diagnosis through treatment and survivorship, we’re here to provide the highest level of support and expertise every step of the way.

Ewing Sarcoma Survival Rates and Prognosis

Survival rates provide general estimates of how likely treatment is to be successful but can’t predict individual outcomes.

According to the SEER database, the 5-year relative survival rate for localized Ewing tumors is 82%, for regional spread is 71%, and for distant spread is 39%. When all stages are combined, the survival rate is about 63%.

These estimates do not reflect personal factors like tumor size, location, response to treatment, or age. Additionally, newer treatments may improve outcomes beyond what the data shows. For the most accurate guidance, talk to your care team.

Why Come to CU Cancer Center for Sarcoma Cancer

As the only National Cancer Institute Designated Comprehensive Cancer Center in Colorado and one of only four in the entire Rocky Mountain region, the University of Colorado Cancer Center has doctors dedicated to the treatment of sarcoma who provide patient-centered sarcoma cancer care and researchers dedicated to diagnostic and treatment innovations.

Two New Grants Help CU Researchers Test New Sarcoma Treatments

The CU Cancer Center is home to the Sarcoma Multidisciplinary Clinic, which offers patients an “all in one” approach to clinical care. At a multidisciplinary clinic, patients are evaluated in one visit by specialists who treat this specific cancer, including world-class medical oncologists, surgical oncologists, orthopedic oncologists, radiation oncologists, interventional radiologists, pathologists, radiologists, nurse practitioners, physician assistants, nurses, social workers, nutritionists, and others, who then collaborate on care. The team also works with plastic surgeons, urologists, thoracic surgeons, cardiologists, and fertility specialists to provide each patient with the optimal course of treatment and follow-up care. Contact the Sarcoma Multidisciplinary Clinic at 720-848-9395.

There are multiple sarcoma clinical trials being offered by CU Cancer Center members at any time. These trials offer patients options beyond traditional sarcoma treatment and can result in remission or increased life spans. Trials conducted by CU Cancer Center doctors have led to the development of some of the most recently approved drugs for sarcoma.

Types of Ewing Sarcomas

Ewing Sarcoma of Bone: This is the most common type, identified by Dr. James Ewing in 1921. Unlike osteosarcoma, Ewing sarcoma cells do not make tumor bone, and often respond better to radiation therapy.

Extraskeletal Ewing Sarcoma (EES): Found in soft tissues , EESs behave similarly to bone-based Ewing sarcomas and are also referred to as Extraskeletal Ewing sarcomas.

Understanding the Causes of Ewing Sarcoma

The exact causes of Ewing sarcomas are not fully understood, but researchers are uncovering how certain changes in a cell's DNA can lead to cancer. DNA, the coding found in each cell, carries the instructions that direct cell function and determines genetic traits. Packaged in chromosomes, DNA plays a crucial role in cell growth, division, and repair.

Genes and Cell Function

  • Oncogenes: Genes that, when altered, can drive cells to grow and divide uncontrollably.
  • Tumor Suppressor Genes: Genes that regulate cell division, repair DNA damage, and trigger cell death when necessary.

Cancer occurs when changes in DNA activate oncogenes or disable tumor suppressor genes. These changes are typically acquired after birth, not inherited.

Ewing tumors are driven by specific DNA changes involving the EWSR1 gene on chromosome 22. In most cases, pieces of DNA from chromosomes 22 and 11 swap places (a translocation), leading to constant activation of the EWSR1 gene. Less commonly, this translocation occurs between chromosome 22 and chromosome 21, or another chromosome. This gene activation causes abnormal cell growth, resulting in Ewing Sarcoma.

In rare cases, the FUS gene on chromosome 16 is involved in similar translocations. Laboratory tests can identify these translocations in tumor samples, helping doctors confirm a diagnosis of Ewing sarcoma.

The genetic changes that lead to Ewing sarcoma are now well-documented, though their root causes remain unclear. These mutations appear to occur randomly within a cell, without external triggers. Unlike some other cancers, there are no known lifestyle or environmental risk factors for Ewing sarcoma. At this time, there are no measures to prevent these tumors.

At the CU Cancer Center, we use the latest research and advanced diagnostic tools to better understand and treat Ewing sarcomas, offering patients the best possible care. Comprehensive DNA and RNA sequencing can identified the causative gene fusions, and detect any additional mutations present in tumor tissue.

Risk Factors for Ewing Sarcoma

Unlike many adult cancers, lifestyle-related factors such as body weight, physical activity, diet, and tobacco or alcohol use do not appear to influence the risk of Ewing sarcomas. These cancers, which mainly affect children and teens, develop over shorter periods and are not linked to long-term lifestyle choices

Environmental and Genetic Risk:

Studies of children with Ewing sarcomas have not identified clear connections to radiation, chemicals, or other environmental exposures. While certain cancers can run in families, inherited genetic changes are not considered a significant risk factor for Ewing sarcomas. The DNA changes that cause these tumors occur after birth and are not passed down from a parent.

Demographic Risk Factors:

  • Race/Ethnicity: Ewing sarcomas are rare overall but are significantly less common among African Americans and Asian Americans compared to White individuals (non-Hispanic or Hispanic).
  • Sex: These tumors occur slightly more often in males than in females.
  • Age: While people of any age can develop Ewing sarcomas, they are most common in older children and teens, less common in young adults and younger children, and rare in older adults.

At the CU Cancer Center, our specialists are dedicated to understanding and addressing the unique characteristics of Ewing sarcomas, providing expert care tailored to each patient's needs.


Symptoms of Ewing Sarcoma

Ewing sarcomas are most common in older children and teens, though they can occur in people of any age. These tumors are often detected because of the symptoms they cause.

Pain

Pain is the most common symptom of Ewing sarcoma. Tumors typically develop in the pelvis (hip bones), chest wall (ribs or shoulder blades), or extremities (particularly the middle of the long bones), though they can arise in other parts of the body. Initially, the pain may come and go, often worsening at night or during activity. Over time, the pain tends to become more intense and constant. In some cases, a person may experience sudden, severe pain due to a fracture in a bone weakened by the tumor.

Lump or Swelling

Most Ewing sarcomas eventually cause a lump or swelling. These are more noticeable when the tumor occurs in the arms or legs. The lump is often soft, warm, and may grow over time. Tumors in areas like the chest wall or pelvis might not become apparent until they have grown significantly.

Other Symptoms

Ewing sarcomas can also cause additional symptoms, particularly if the cancer has spread:

  • Fever
  • Fatigue
  • Weight loss

Rarely, tumors located near the spine may press on nerves, causing back pain, weakness, numbness, or even paralysis in the arms or legs. Tumors that spread to the lungs can result in shortness of breath.

Ewing Sarcoma: Diagnosis and Testing

Ewing sarcomas are typically identified after a person experiences concerning symptoms. If a tumor is suspected, diagnostic tests and procedures including biopsy are performed to confirm its presence and determine its characteristics.

Diagnosis Challenges

Many symptoms of Ewing sarcoma resemble those of more common issues like infections or injuries. For instance, a doctor may initially prescribe antibiotics if an infection is suspected. If symptoms persist or worsen, further investigation—such as an X-ray—might reveal the tumor.

Anyone experiencing these symptoms, especially if they do not improve, should consult a doctor to identify the cause and receive appropriate care.

Medical History and Physical Examination

Doctors start by gathering a comprehensive medical history to understand the symptoms and their duration. A physical examination follows, focusing on any pain or swelling. If a tumor is suspected, further tests such as imaging studies, biopsies, and laboratory evaluations are conducted.

Imaging Tests

Imaging tests provide detailed pictures of the body to help identify tumors, evaluate their size, and check for cancer spread. Common imaging methods include:

  • X-rays: Often the first step when a bone tumor is suspected, x-rays can reveal abnormalities.
  • MRI Scans: MRI uses magnets and radio waves to produce detailed images, particularly helpful in showing tumor extent in bones and nearby tissues. Contrast agents enhance image clarity. A biopsy is needed to confirm a diagnosis.
  • CT Scans: These scans create detailed cross-sectional images of the body. They are frequently used to check for lung metastases and evaluate tumor details.
  • Bone Scans: Radioactive material highlights areas of bone activity, useful for detecting cancer spread throughout the skeleton.
  • PET Scans: PET scans identify active cancer cells using radioactive sugar. These scans are valuable for staging and monitoring tumor spread and treatment progress.

Biopsy Procedures

A biopsy is essential to confirm a diagnosis of Ewing sarcoma. An orthopedic surgeon experienced in treating bone tumors typically performs the biopsy. Careful planning ensures the procedure supports subsequent treatment.

  • Core Needle Biopsy: Generally done with imaging guidance, this percutaneous, minimally invasive technique takes a core tissue sample from the tumor. Majority of musculoskeletal tumors are diagnosed in this manner.
  • Incisional Biopsy: Involves removing a portion of the tumor, surgically
  • Excisional Biopsy: In rare cases, a small tumor may be completely removed during biopsy.

During the biopsy, additional procedures such as sampling nearby tumors or placing a central venous catheter may be performed to streamline treatment preparation.

Bone Marrow Aspiration and Biopsy

These procedures check if the cancer has spread to the bone marrow. A small sample of bone and marrow is taken, usually from the pelvis, under local or general anesthesia.

Lab Testing of Biopsy Samples

Pathologists examine biopsy samples under a microscope and conduct specialized tests, including:

  • Immunohistochemistry: Identifies specific protein markers expressed by Ewing sarcoma cells.
  • Molecular Tests: Detect translocations in tumor cell DNA or RNA, particularly between chromosomes 11 and 22. Methods include cytogenetics, FISH, PCR, and next-generation sequencing.

Blood Tests

Blood tests can’t diagnose Ewing sarcoma but provide supportive information:

  • Complete Blood Count (CBC)
  • LDH Levels: High lactate dehydrogenase levels suggest more extensive disease.
  • Blood Chemistry Tests: Monitor liver and kidney function during treatment.

These diagnostic steps ensure a thorough understanding of the tumor, guiding effective treatment planning.

Stages

Once Ewing Sarcoma is diagnosed, additional tests help determine its stage, or how much cancer is in the body. The stage indicates the severity of the cancer and helps guide treatment decisions. It is also used when discussing survival statistics. Staging is based on imaging tests and biopsies of the main tumor and any affected tissues, as explained in Ewing Sarcoma.

A staging system provides a standardized way for the care team to summarize the cancer’s extent. Different cancers use different staging systems. For Ewing tumors, the American Joint Committee on Cancer (AJCC) has formal systems for bone cancers and soft tissue sarcomas. However, for treatment purposes, a simpler classification—localized or metastatic—is often used.

Localized vs. Metastatic Ewing Tumors

When planning treatment, doctors typically classify Ewing tumors as localized or metastatic.

  • Localized Ewing Tumors: A tumor is considered localized if it is only found in the area where it started or in nearby tissues, such as muscles or tendons. This determination is made after all tests, including x-rays, CT scans, MRIs, PET scans, bone scans, or bone marrow biopsies, show no signs of the cancer spreading to distant parts of the body.
    • Even if tests don’t detect cancer in other areas, many patients likely have micrometastases (small cancerous areas undetectable by imaging tests). This is why chemotherapy, which treats the whole body, is a critical part of treatment for all Ewing Sarcoma.
  • Metastatic Ewing Sarcoma: A metastatic Ewing Sarcoma has spread to distant parts of the body. Most commonly, it spreads to the lungs, bones, or bone marrow, though less frequently to the liver or lymph nodes. About 20% of patients show clear signs of cancer spread on imaging tests. However, small amounts of undetectable spread may still exist in others.

Ewing Sarcoma staging can feel overwhelming. Be sure to ask your care team any questions to better understand the stage and what it means for treatment.


Localized Ewing Sarcoma

Localized tumors appear confined to their original area (and possibly nearby tissues), but even then, microscopic cancer cells may be present elsewhere in the body. Chemotherapy (chemo) is essential in these cases, as it targets undetectable cancer cells that could form new tumors if untreated.

  1. Initial Treatment: Chemotherapy begins after diagnosis and staging. In the U.S., the typical regimen, VDC/IE (vincristine, doxorubicin, and cyclophosphamide alternated with ifosfamide and etoposide), is administered before and after treatment of the primary tumor with surgery and/or radiation therapy.
  2. Assessment: After at least nine weeks of chemo, imaging tests (CT, MRI, PET, or bone scans) Are repeated to assess response to treatment.

If surgery is viable, the tumor is removed, and a pathologist examines the specimen:

  • Positive Margins: Tumor is present at the edge of the removed tissues.
  • Negative Margins: There are healthy non-tumor tissues present at the edge of the removed tissues.

As Ewing sarcoma is radiation sensitive, the decision for treatment of the primary tumor is a multidisciplinary discussion that takes into account patient and tumor specific variables, disease stage, and impact of local control treatment on near and long-term outcomes and complications.

For tumors unresponsive to the initial regimen, alternative chemo combinations, surgery, or radiation therapy may be tried.

Metastatic Ewing Sarcoma

Metastatic tumors, particularly those spreading beyond the lungs, are harder to treat. Intensive chemotherapy is the first step, followed by tests to evaluate the cancer’s response. If only a few small areas remain, treatment options include:

  • Surgery to remove the primary tumor and metastases
  • Radiation therapy for remaining areas
  • Chemotherapy for several months

For certain cases, high-dose chemo followed by stem cell transplants is being studied. Clinical trials often provide new treatment options for metastatic Ewing tumors.

Recurrent Ewing Sarcoma

If a tumor returns, treatment depends on its size, location, spread, prior treatments, and time since the last treatment. Options include chemo, surgery, radiation therapy, or a combination. Clinical trials for high-dose chemo, stem cell transplants, and targeted or immune therapies may offer hope in these cases.

Chemotherapy

Chemotherapy target cancer throughout the body, making them crucial for Ewing tumors, which often have undetected microscopic spread. Chemo is typically administered in cycles, alternating treatment days with recovery periods.

Common Regimen

The most common regimen, VDC/IE, alternates two drug combinations:

  • VDC: Vincristine, doxorubicin, cyclophosphamide
  • IE: Ifosfamide, etoposide

Patients receive chemo for at least nine weeks pre-surgery or radiation, with additional cycles afterward, totaling 14–15 cycles over 6–12 months.

Side Effects

Chemo side effects vary based on drugs and doses. Common effects include:

  • Hair loss, mouth sores, nausea, vomiting, diarrhea, and appetite loss
  • Low blood cell counts, increasing infection risk, bruising, or fatigue
  • Specific drugs may cause unique issues:
    • Cyclophosphamide/Ifosfamide: Bladder damage (preventable with fluids and mesna)
    • Doxorubicin: Heart damage, monitored with echocardiograms
    • Vincristine: Nerve damage (numbness/tingling)
    • Etoposide: Rarely linked to later leukemia

Long-term side effects, including fertility issues or secondary cancers, should be discussed with the care team.

Surgery for Ewing Sarcoma

Surgery is key option for removing tumors. The main goal is complete tumor removal with negative margins, often with surrounding healthy tissue, to prevent recurrence. A pathologist examines the tissue margins to confirm whether cancer cells remain.

Limb-Sparing Surgery

For tumors in arms or legs, limb-sparing surgery removes affected bone and replaces it with bone grafts or internal metal prostheses or bone transport. These procedures are complex and require skilled surgeons. Expandable prosthetics are used in children with significant remaining growth in order to help maintain as close as possible limb lengths. Another unique option is rotationplasty for patients who want a biologic surgical option and less need for future surgeries and less activity restrictions.

Challenges

Tumors in areas like the skull base, spine, chest wall, or pelvis can be harder to remove and may require different approaches.

For tumors that cannot be completely removed surgically or in which the complications of surgery is deemed to significant, like in the spine, radiation therapy is typically combined with other treatments.

Radiation Therapy and Stem Cell Transplants for Ewing Tumors

Radiation Therapy

Radiation therapy uses high-energy beams targeted at tumors to destroy cancer cells. Ewing sarcomas are highly sensitive to radiation, making this treatment an option alongside or instead of surgery. When surgery isn’t feasible, radiation therapy, often combined with chemotherapy, can be effective.

How Radiation Therapy is Performed

Administered by a radiation oncologist, treatment begins with a planning session called simulation. Imaging tests like MRI scans determine the tumor's location and the appropriate radiation dose. Patients may wear a plastic mold to maintain consistent positioning during treatments. Sessions occur five days a week over several weeks. Each session involves the patient lying on a table while radiation is delivered from specific angles. Treatments are brief, but setup can take longer, particularly for younger children who may require sedation to prevent movement.

Modern Radiation Techniques

Advances in technology allow for more precise targeting of radiation, minimizing damage to healthy tissue:

  • 3D Conformal Radiation Therapy (3D-CRT): Uses imaging to map the tumor and deliver focused beams from various directions.
  • Intensity-Modulated Radiation Therapy (IMRT): Adjusts beam strength for complex tumors or those near sensitive areas like the spine.
  • Conformal Proton Beam Therapy: Uses proton beams to release energy directly at the tumor, sparing nearby tissues.

Possible Side Effects of Radiation Therapy

Side effects depend on the radiation dose and the targeted area.

  • Short-term effects include skin irritation, lowered blood cell counts, nausea, and mouth sores.
  • Long-term effects in growing children can involve slowed bone growth, organ damage, fertility issues, or secondary cancers.

Stem Cell Transplants for Ewing Sarcomas

For advanced or recurrent Ewing Sarcomas, high-dose chemotherapy combined with a stem cell transplant may be considered. While still under study, this approach can provide higher chemo doses by rescuing damaged bone marrow with stem cells.

Stem Cell Transplant Procedure

Patients undergo initial chemo and local treatment (surgery or radiation) before the transplant. Blood stem cells are harvested, frozen, and later infused after high-dose chemo to restore bone marrow function.

Side Effects of Stem Cell Transplants

This intensive treatment carries risks like severe side effects from chemotherapy. Long-term concerns, especially in children, include delayed effects on growth and organ function. Stem cell transplants should be performed at specialized centers equipped to manage recovery.

By utilizing cutting-edge techniques and tailored treatments, radiation therapy and stem cell transplants offer hope for managing complex Ewing tumors.

The University of Colorado (CU) Cancer Center partners with UCHealth, Children’s Hospital Colorado, and Rocky Mountain Regional VA to provide clinical care. Please make an appointment with one of our clinical partners to be seen by a CU Cancer Center doctor.


UCHealth:

UCHealth Cancer Care - Anschutz Medical Campus
1665 Aurora Court Anschutz Cancer Pavilion
Aurora, CO 80045
720-848-0300

UCHealth Cherry Creek Medical Center
100 Cook Street
Denver, CO 80206
720-848-0000

UCHealth Cancer Center - Highlands Ranch
1500 Park Central Drive
Highlands Ranch, CO 80129
720-516-1100

UCHealth Lone Tree Medical Center
9548 Park Meadows Drive
Lone Tree, CO 80124
720-848-2200


Children's Hospital Colorado:
13123 East 16th Avenue
Aurora, CO 80045
720-777-6740


Rocky Mountain Regional VA Medical Center:
1700 North Wheeling Street
Aurora, CO 80045-7211
303-399-8020


 

Latest in Sarcoma from the CU Cancer Center

Loading items....

Information reviewed by Michael Clay, MD and Steven Thorpe, MD, FACS, FAOA in May 2025.
CMS Login